{"filing":{"accession_number":"0001493152-26-037979","cik":"0001763950","ticker":"LTRN","company_name":"Lantern Pharma Inc.","form":"8-K","filing_date":"2026-08-14","report_date":"2026-08-14","primary_document":"form8-k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1763950/000149315226037979/form8-k.htm"},"events":[{"id":27729,"run_id":25304,"accession_number":"0001493152-26-037979","anchor_item_number":null,"event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"summary":"The filing discloses Q2 2026 financial results for Lantern Pharma via a press release dated August 14, 2026 (Item 2.02). The press release reports second quarter loss from operations of approximately $3.5 million (down 25% year-over-year), cash position of $7.4 million as of June 30, 2026, and gross proceeds of $4.4 million from a registered direct offering. While the filing also includes operational updates on clinical trials and the establishment of Open Medicine AI as a separate company, the primary disclosure mechanism is the earnings release attached as Exhibit 99.1.","company_name":"Lantern Pharma Inc.","ticker":"LTRN","filing_date":"2026-08-14","form":"8-K","submitted_at":null,"items":null}],"classifications":[{"id":29384,"accession_number":"0001493152-26-037979","item_number":null,"item_title":null,"event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"The filing discloses Q2 2026 financial results for Lantern Pharma via a press release dated August 14, 2026 (Item 2.02). The press release reports second quarter loss from operations of approximately $3.5 million (down 25% year-over-year), cash position of $7.4 million as of June 30, 2026, and gross proceeds of $4.4 million from a registered direct offering. While the filing also includes operational updates on clinical trials and the establishment of Open Medicine AI as a separate company, the primary disclosure mechanism is the earnings release attached as Exhibit 99.1.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-14T11:36:38.086130+00:00","company_name":"Lantern Pharma Inc.","ticker":"LTRN","filing_date":"2026-08-14"}]}